Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours

19:30 EDT 1 May 2019 | Proactive Investors

The oncology-focused biotech is a mid-clinical-stage therapeutics company.

More From BioPortfolio on "Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours"